Gut Microbiota Interactions with Dietary Lipids

The gut microbiota and dietary lipids engage in a dynamic reciprocity that shapes host physiology, metabolic health and immune homeostasis. Lipids consumed in the diet act both as substrates for microbial metabolism and as modulators of microbial community structure. Saturated fatty acids, unsaturated fatty acids and bile acids each exert selective pressures on bacterial taxa, altering the balance of Firmicutes, Bacteroidetes and other key phyla. In turn, the microbiota transforms primary bile acids into secondary bile acids, ferments lipids into short-chain fatty acids and produces lipid-derived mediators such as trimethylamine, which influence host lipid absorption, energy expenditure, inflammatory tone and lipid storage. Dysbiosis arising from high-fat diets or imbalanced fatty acid ratios can promote metabolic endotoxemia via lipopolysaccharide translocation, contribute to non-alcoholic fatty liver disease and exacerbate obesity, insulin resistance and cardiovascular risk. Conversely, specific lipid–microbiota interactions, for example involving polyunsaturated fatty acids, can enrich beneficial taxa, enhance intestinal barrier integrity and attenuate chronic low-grade inflammation. Recent advances have begun to unravel molecular mechanisms, including bile acid receptor signalling and lipid-sensing pathways, that underpin the gut–liver, gut–adipose and gut–brain axes.

Research from Nature Portfolio

Recent studies have demonstrated that dietary long-chain saturated fatty acids, particularly stearic acid, can reshape the gut microbial community to favour bile acid modifications that protect against hepatic steatosis and improve systemic metabolism. These beneficial effects are transmissible via microbial transfer, and are independent of dietary fibre intake. Another seminal investigation has revealed that the ratio of tissue omega-6 to omega-3 fatty acids modulates metabolic endotoxaemia through microbiota-dependent induction of intestinal alkaline phosphatase. Enhanced omega-3 levels promote beneficial shifts in bacterial composition, reduce lipopolysaccharide production, improve gut barrier function and thus lower systemic inflammation.

Gut Microbiota Interactions with Dietary Lipids publication trend

The graph below shows the total number of articles in gut microbiota interactions with dietary lipids across all publications each year (not limited to Nature Index journals).

Technical terms

Short-chain fatty acids (SCFAs): Fatty acids with fewer than six carbon atoms produced by microbial fermentation of dietary substrates, important for colonocyte energy and immune modulation.

Bile acids: Cholesterol-derived molecules secreted into the intestine that facilitate fat absorption and act as signalling ligands, transformed by gut bacteria into secondary bile acids.

Metabolic endotoxaemia: Low-grade elevation of circulating bacterial lipopolysaccharide that triggers systemic inflammation and contributes to metabolic disease.

Steatosis: Accumulation of lipid droplets in hepatocytes, often associated with insulin resistance and progression to non-alcoholic fatty liver disease.

Dysbiosis: Disruption of the normal microbial community structure, leading to increased pathogenic taxa and loss of beneficial functions.

Omega-3 and omega-6 fatty acids: Essential polyunsaturated fatty acids that must be obtained from diet; their balance influences inflammatory pathways and microbial ecology.

References

1. New insights into the mechanisms of high‐fat diet mediated gut microbiota in chronic diseases. iMeta (2023).
2. The interplay between dietary fatty acids and gut microbiota influences host metabolism and hepatic steatosis. Nature Communications (2023).
3. Dietary lipids, gut microbiota and lipid metabolism. Reviews in Endocrine and Metabolic Disorders (2019).
4. A host-microbiome interaction mediates the opposing effects of omega-6 and omega-3 fatty acids on metabolic endotoxemia. Scientific Reports (2015).
5. Associations among Dietary Omega‐3 Polyunsaturated Fatty Acids, the Gut Microbiota, and Intestinal Immunity. Mediators of Inflammation (2021).
6. Correlations between α-Linolenic Acid-Improved Multitissue Homeostasis and Gut Microbiota in Mice Fed a High-Fat Diet. mSystems (2020).